Clinical data | |
---|---|
Trade names | Tolopelon |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.055.328 |
Chemical and physical data | |
Formula | C22H24FN3OS |
Molar mass | 397.51 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Timiperone, sold under the brand name Tolopelon, is a typical antipsychotic of the butyrophenone class which is marketed in Japan for the treatment of schizophrenia.[1][2][3][4] It is similar in chemical structure to benperidol, but has a thiourea group instead of a urea group. It acts as an antagonist for the D2 and 5-HT2A receptors.[4]